Assetmark Inc. lifted its position in Morgan Stanley (NYSE:MS – Free Report) by 7.0% during the 1st quarter, HoldingsChannel reports. The firm owned 171,725 shares of the financial services provider’s stock after buying an additional 11,305 shares during the period. Assetmark Inc.’s holdings in Morgan Stanley were worth $28,261,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Norges Bank purchased a new position in Morgan Stanley during the fourth quarter worth about $2,736,648,000. Price T Rowe Associates Inc. MD raised its holdings in shares of Morgan Stanley by 29.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 14,917,776 shares of the financial services provider’s stock valued at $2,648,354,000 after acquiring an additional 3,364,080 shares in the last quarter. Corient Private Wealth LLC raised its holdings in shares of Morgan Stanley by 142.4% in the 4th quarter. Corient Private Wealth LLC now owns 3,122,060 shares of the financial services provider’s stock valued at $511,723,000 after acquiring an additional 1,833,844 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Morgan Stanley by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 119,718,100 shares of the financial services provider’s stock valued at $21,253,554,000 after acquiring an additional 1,361,940 shares during the last quarter. Finally, Thrivent Financial for Lutherans boosted its position in shares of Morgan Stanley by 2,332.9% during the 4th quarter. Thrivent Financial for Lutherans now owns 1,406,495 shares of the financial services provider’s stock valued at $249,710,000 after acquiring an additional 1,348,683 shares during the last quarter. Hedge funds and other institutional investors own 84.19% of the company’s stock.
Morgan Stanley Price Performance
MS opened at $215.27 on Friday. The company has a debt-to-equity ratio of 3.52, a current ratio of 0.77 and a quick ratio of 0.77. The stock’s 50 day simple moving average is $211.69 and its 200 day simple moving average is $188.71. The firm has a market cap of $339.54 billion, a price-to-earnings ratio of 17.40, a PEG ratio of 1.61 and a beta of 1.23. Morgan Stanley has a 1 year low of $136.17 and a 1 year high of $232.25.
Morgan Stanley Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 31st will be issued a dividend of $1.15 per share. The ex-dividend date is Friday, July 31st. This represents a $4.60 dividend on an annualized basis and a yield of 2.1%. This is an increase from Morgan Stanley’s previous quarterly dividend of $1.00. Morgan Stanley’s dividend payout ratio (DPR) is currently 37.19%.
Morgan Stanley declared that its Board of Directors has approved a stock repurchase plan on Wednesday, June 24th that permits the company to buyback $20.00 billion in shares. This buyback authorization permits the financial services provider to purchase up to 5.6% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its stock is undervalued.
Key Headlines Impacting Morgan Stanley
Here are the key news stories impacting Morgan Stanley this week:
- Positive Sentiment: Morgan Stanley reported blockbuster Q2 2026 results, with record net revenues of about $21.3 billion and earnings that beat expectations, reinforcing confidence in the company’s core businesses. Morgan Stanley (MS) Q2 2026 Earnings Call Highlights: Record Revenues and Strategic Growth …
- Positive Sentiment: The board declared a quarterly dividend of $1.15 per share, a 15% increase from the prior quarter, which signals confidence in earnings power and capital return capacity.
- Positive Sentiment: Analysts turned more constructive after the earnings release, with Keefe, Bruyette & Woods raising its price target to $250 and Erste Group lifting FY2027 EPS estimates, suggesting more upside may remain. Morgan Stanley had its price target raised by Keefe, Bruyette & Woods from $225.00 to $250.00
- Neutral Sentiment: New reports also pointed to Morgan Stanley’s E*TRADE crypto rollout and AI-related market activity, which could help broaden its platform appeal over time but are not likely the main short-term drivers of the stock move.
- Negative Sentiment: Some articles noted a downgrade-style view from Seeking Alpha and a JPMorgan target below the current share price, which may temper enthusiasm at the margin even after the strong earnings beat. Morgan Stanley Maintains Hold on Comstock Resources, Keeps Price Target Unchanged at $16 Amid Cash Outspend and Funding Concerns
Analyst Ratings Changes
Several research analysts recently weighed in on the stock. Wolfe Research decreased their price objective on shares of Morgan Stanley from $221.00 to $197.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 1st. Citigroup lifted their target price on shares of Morgan Stanley from $220.00 to $235.00 and gave the company a “neutral” rating in a research report on Friday. JPMorgan Chase & Co. boosted their price target on shares of Morgan Stanley from $187.00 to $195.00 and gave the stock a “neutral” rating in a research note on Thursday. Citizens Jmp reissued a “market perform” rating on shares of Morgan Stanley in a report on Thursday, April 16th. Finally, Jefferies Financial Group upgraded shares of Morgan Stanley from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 7th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $220.80.
Check Out Our Latest Report on Morgan Stanley
Insider Buying and Selling
In other Morgan Stanley news, insider Eric F. Grossman sold 11,118 shares of the stock in a transaction on Monday, April 20th. The shares were sold at an average price of $190.75, for a total transaction of $2,120,758.50. Following the completion of the sale, the insider owned 169,403 shares of the company’s stock, valued at $32,313,622.25. This represents a 6.16% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.17% of the stock is owned by corporate insiders.
Morgan Stanley Company Profile
Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.
The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
Read More
- Five stocks we like better than Morgan Stanley
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
